Lexicon Pharmaceuticals Inc
F:LX31
Lexicon Pharmaceuticals Inc
F:LX31
Price:
2.894
EUR
-2.69%
Market Closed
Market Cap:
€418.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Lexicon Pharmaceuticals Inc
F:LX31
|
US |
|
77 Bank Ltd
TSE:8341
|
JP |
|
S
|
Sinda Ltd
NYSE:SIND
|
MX |
|
Calida Holding AG
LSE:0QP3
|
CH |
|
A
|
Aarti Pharmalabs Ltd
BSE:543748
|
IN |
|
C
|
Chime Financial Inc
NASDAQ:CHYM
|
US |
|
F
|
Festi hf
ICEX:FESTI
|
IS |
|
Azelis Group NV
XBRU:AZE
|
BE |
|
C
|
Cantargia AB
F:7V3
|
SE |
|
P
|
Precision BioSciences Inc
XBER:PBS
|
US |
|
Austco Healthcare Ltd
ASX:AHC
|
AU |
|
Pharmagest Interactive SA
LSE:0R9T
|
FR |
|
G
|
Goldplat PLC
SWB:G7N
|
UK |
|
Orora Ltd
ASX:ORA
|
AU |
|
Precision BioSciences Inc
NASDAQ:DTIL
|
US |
|
G
|
Gilat Satellite Networks Ltd
TASE:GILT
|
IL |
|
BRAIN Biotech AG
LSE:0RFI
|
DE |
|
F
|
Fresenius SE & Co KGaA
XHAN:FRE
|
DE |
|
B
|
Block Inc
XBER:SQ3
|
US |
Multiples-Based Value
The Multiples-Based Value for 
Lexicon Pharmaceuticals Inc (LX31) under the Base Case is hidden
EUR.
Compared with the current market price of 2.894 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LX31 Multiples-Based Value
LOCKED
